Cargando…
Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells
Cancer stem cells (CSCs) are believed to be the main cause of chemotherapy resistance and tumor relapse. Various therapeutic strategies to eliminate CSCs have been developed recently. Aptamers, also called “chemical antibodies”, can specifically bind with their molecular targets through special tert...
Autores principales: | Liu, Biao, Liu, Jiahao, Hu, Xing, Xiang, Wei, Hou, Weibin, Li, Chao, Wang, Jinrong, Yao, Kun, Tang, Jin, Long, Zhi, Wang, Long, Liu, Jianye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034522/ https://www.ncbi.nlm.nih.gov/pubmed/36969696 http://dx.doi.org/10.1016/j.mtbio.2023.100605 |
Ejemplares similares
-
Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate
por: Xiang, Wei, et al.
Publicado: (2022) -
The regulatory role of antisense lncRNAs in cancer
por: Liu, Biao, et al.
Publicado: (2021) -
Recent Advances in Micro/Nanomaterial-Based Aptamer Selection Strategies
por: Kim, Dong-Min, et al.
Publicado: (2021) -
Recent Advances in Aptamer Sensors
por: Shaban, Samy M., et al.
Publicado: (2021) -
Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
por: Zhuo, Zhenjian, et al.
Publicado: (2017)